Nasdaq
DMAC
DiaMedica Therapeutics Inc.
- Health Care
- Listed 2018
- 1 day
- +1.6%
- 1 month
- −15.3%
- 1 year
- +43.4%
$6.77 · Mkt cap $365M
At the 6 Aug 2026 close
Nasdaq
DiaMedica Therapeutics Inc.
$6.77 · Mkt cap $365M
At the 6 Aug 2026 close
DiaMedica Therapeutics Inc. trades under the ticker DMAC on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2018. Its market capitalisation is $365M. The last closing price was $6.77, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +43.4%, and −15.3% over the past month. Returns are price returns and exclude dividends.
This page exists because DMAC is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.